Nmrd stock.

Stock Symbol NASDAQ:NMRD. Funding Rounds 5. Total Funding Amount $46.5M. Total Funding Amount . Unlock for free . Lead Investors 1. Investors 1. Funding. Nemaura Medical has raised a total of . $46.5M. in funding over 5 rounds. Their latest funding was raised on Nov 21, 2023 from a Post-IPO Debt round. Nemaura Medical is registered under the …The company is currently trading at around $7 (52-Week Range: $3.12-$17.40) and has a market cap of ~ $163 M. NMRD's total number of outstanding shares and float is 23.3 M, and 9.1 M respectively ...Dec 1, 2023 · Get Nemaura Medical Inc (NMRD.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Dec 1, 2023 · NMRD Earnings Date and Information. Nemaura Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, February 23rd, 2024 based off prior year's report dates.

The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Jan-27-23 08:20AM. Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement. (GlobeNewswire) -42.31%. Jan-26-23 09:57AM. Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023) Nemaura Medical ( NASDAQ:NMRD ) First Half 2024 Results Key Financial Results Net loss: US$3.81m (loss narrowed by 52... Find the latest Nemaura Medical Inc. (NMRD) stock quote, history, news and other vital information to help you with your stock ...

Nov 21, 2023 · 11/21/2023 - 08:30 AM. Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agreement for a $10 million credit facility which ...

Sep 14, 2023 · Nemaura Medical Inc (NMRD) Stock Shows Potential for +1,140% Growth, Analysts Say. Nemaura Medical Inc (NMRD) is a company that has been attracting attention from investors due to its potential for growth. On September 14, 2023, the stock’s performance was closely monitored by analysts and investors alike. LOUGHBOROUGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing ...Oct 6, 2022 · The 51 rating InvestorsObserver gives to Nemaura Medical Inc ( NMRD) stock puts it near the middle of the Medical Devices industry. In addition to scoring higher than 59 percent of stocks in the Medical Devices industry, NMRD’s 51 overall rating means the stock scores better than 51 percent of all stocks. NMRD has an Overall Score of 51. NMRD Nemaura Medical Inc Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement LOUGHBOROUGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) ('Nemaura' or the 'Company'), a medical technology company focused on developing and commercializing non-invasive...21 thg 11, 2023 ... Stock Quotes. Get quotes for stocks: To display multiple quotes,enter symbols with a comma separating each symbol (e.g. F,MSFT,GOOG) ...

Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...

Sonendo (NYSE:SONX) on Monday said it has received notice from NYSE that the company is not in compliance with continued listing standard, as the average closing price of its common stock was less ...

Loughborough, England, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT ®, a non-invasive and flexible continuous glucose monitor (CGM), together with BEAT ® diabetes, a health subscription service designed to help …On September 13, 2023, NMRD stock opened at $0.41 and fluctuated between a low of $0.41 and a high of $0.47. The trading volume for the day was 8,049 shares, significantly lower than the average volume over the past three months. NMRD has a market capitalization of $11.6 million and reported earnings growth of +4.28% for the last year.Jul 2, 2021 · NMRD stock is going to be up > 50% in just one day. And it is going to happen anyday within the next 6 - 9 months. And that will be the beginning of a gradual quick uptrend thereafter. Jul 2, 2021 · NMRD stock is going to be up > 50% in just one day. And it is going to happen anyday within the next 6 - 9 months. And that will be the beginning of a gradual quick uptrend thereafter. 22 thg 8, 2023 ... Live updates on what's moving markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. FOXO Technologies Inc.’s current trading price is -98.63% away from its 52-week high, while its distance from the 52-week low is 0.13%. The stock’s pricNemaura Medical Inc (NMRD) stock has gained 4.4% while the S&P 500 is lower by -2.87% as of 1:21 PM on Thursday, Dec 22. NMRD is higher by $0.08 from the previous closing price of $1.82 on volume of 3,402 shares. Over the past year the S&P 500 is down -19.79% while NMRD is lower by -59.75%. NMRD lost -$0.63 per share the over the last 12 months.

Sonendo (NYSE:SONX) on Monday said it has received notice from NYSE that the company is not in compliance with continued listing standard, as the average closing price of its common stock was less ...Feb 8, 2021 · NMRD stock joined the Nasdaq Exchange in January 2018 and was trading on the OTCQB prior to that. NMRD stock was up 41.5% as of Monday morning. On the date of publication, William White did not ... Alternatively, NMRD is performed by transporting samples between persistent high- and ultralow-field locations 16,17,18,19,20, but relatively slow transport times limit the observable τ c at the ...Mar 9, 2023 · LOUGHBOROUGH, March 09, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing ... MicroAlgo (NASDAQ:MLGO) Trading Up 23%. Ticker Report • 2 months ago. Track MicroAlgo Inc (MLGO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Nov 16, 2017 · Nemaura Medical is a medical technology company that manufactures continuous glucose monitoring systems for diabetes and pre-diabetes. The stock has a consensus rating of Buy, a price target of $4.25, and a market cap of $7.23 million. See the latest news, analysis, and earnings reports for NMRD on MarketBeat. Nemaura is listed on NASDAQ since January 2018 as NMRD. However, due to poor performance (a below than $35m market cap) and low trading volumes it was threatened with delisting from NASDAQ (in April 2023). It remains listed on NASDAQ as of the beginning of September 2023. SugarBeat is expected to be launched by 2018 in UK …

The compNemaura Medical (NMRD) said early Wednesday it received a purchase order for 200,000 sugarBEAT sensors and 5,000 sugarBEAT transmitters from its UK licensee DB Ethitronix. Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The comp. by UnknownUnicorn19246015. May 5, 2021.

Nemaura is listed on NASDAQ since January 2018 as NMRD. However, due to poor performance (a below than $35m market cap) and low trading volumes it was threatened with delisting from NASDAQ (in April 2023). It remains listed on NASDAQ as of the beginning of September 2023. SugarBeat is expected to be launched by 2018 in UK …Loughborough, England, April 13, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced the …Investor Relations. Nemaura Medical, Inc. (NMRD), is a medical technology company developing non-invasive and minimally invasive wearable diagnostic devices, coupled with artificial intelligence …Find the latest Nemaura Medical Inc. (NMRD) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Nemaura Medical is a medical technology company that manufactures continuous glucose monitoring systems for diabetes and pre-diabetes. The stock has a consensus rating of Buy, a price target of $4.25, and a market cap of $7.23 million. See the latest news, analysis, and earnings reports for NMRD on MarketBeat.Nemaura Medical Inc (NMRD) Stock Forecast: Potential 3,169.23% Increase and Analysts Consensus to Buy. On November 21, 2023, Nemaura Medical Inc (NMRD) stock had a median target price of $8.50, indicating a potential increase of +3,169.23%. The consensus among investment analysts is to buy the stock. The company reported sales of $200.0K …

NMRD: Nemaura Medical Inc - Stock Price, Quote and News - CNBC

Get the latest news and real-time alerts from Nemaura Medical Inc. (NMRD) stock at Seeking Alpha.

Nov 29, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Nemaura Medical stock is Buy based on the current 2 buy ratings for NMRD. The average twelve-month price prediction for Nemaura Medical is $4.25 with a high price target of $6.00 and a low price target of $2.50. Learn more on NMRD's analyst rating history. Loughborough, England , March 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – March 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics …Find the latest Agri-Fintech Holdings, Inc. (TMNA) stock quote, history, news and other vital information to help you with your stock trading and investing.These Healthcare stocks are trading higher: -Lexicon Pharmaceuticals, Inc. (LXRX) stock is trading at $2.70, an increase of $0.76, or 40.21%, on high volume. Lexicon PharmaceutcNemaura Medical Stock Earnings. The value each NMRD share was expected to gain vs. the value that each NMRD share actually gained. Nemaura Medical ( NMRD) reported Q2 2023 earnings per share (EPS) of -$0.09, beating estimates of -$0.15 by 39.93%. In the same quarter last year, Nemaura Medical 's earnings per share (EPS) was -$0.16.SBL Cybersecurity. SBL Cybersecurity is an information technology and services company that specializes in cybersecurity. It provides penetration testing, cybersecurity assessment, and security monitoring services and solutions. It was founded in 2019. It is based in Voorburg, Netherlands. Zaisan.The trading volume for NMRD stock on this day was 300 shares, which is significantly lower than the average volume of 178,212 shares over the past three months. NMRD has a market capitalization of $11.2 million. The company’s earnings growth for the last year was reported at +4.28%. The revenue growth for NMRD in the last year was …LOUGHBOROUGH, Sep. 13, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced interim results from its metabolic ...

Loughborough, England, March 28, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – March 28, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics …Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor (“CGM”), together with BEAT®diabetes, a planned health subscription …If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Instagram:https://instagram. australian openershow much gold coin worthsandp 400 todayhow much is the mercedes avtr Find the latest Nemaura Medical Inc. (NMRD) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Sonendo (NYSE:SONX) on Monday said it has received notice from NYSE that the company is not in compliance with continued listing standard, as the average closing price of its common stock was less ... best online financial advisorsvleo stock price Stock market mixed after strong hiring data fans inflation worries · U.S. stocks tumble with election results still up in the air · Stocks plummet after Fed ...Nemaura is listed on NASDAQ since January 2018 as NMRD. However, due to poor performance (a below than $35m market cap) and low trading volumes it was threatened with delisting from NASDAQ (in April 2023). It remains listed on NASDAQ as of the beginning of September 2023. hot penny stock According to 2 analysts, the average rating for NMRD stock is "Strong Buy." The 12-month stock price forecast is $3.25, which is an increase of 1,259.26% from the …EV charging stocks are capturing investors' attention following Tesla's charging deals with automakers. Fool.com contributor Parkev Tatevosian discusses why he thinks so many investors are ...Feb 1, 2023 · Nemaura Medical Inc (NMRD) stock has risen 7.53% while the S&P 500 is down -0.52% as of 1:14 PM on Wednesday, Feb 1. NMRD is up $0.10 from the previous closing price of $1.33 on volume of 473,449 shares. Over the past year the S&P 500 has fallen -10.80% while NMRD is down -64.95%. NMRD lost -$0.63 per share in the over the last 12 months.